Chrysostomi Gialeli

Associate Researcher
More filtering options
  1. 2019
  2. 2018
  3. Novel potential inhibitors of complement system and their roles in complement regulation and beyond

    Chrysostomi Gialeli, Bilgi Gungor & Anna M. Blom, 2018, In : Molecular Immunology. 102, p. 73-83 11 p.

    Research output: Contribution to journalArticle

  4. 2016
  5. Synthesis and antiproliferative activity of two diastereomeric lignan amides serving as dimeric caffeic acid-l-DOPA hybrids

    George E. Magoulas, Andreas Rigopoulos, Zoi Piperigkou, Chrysostomi Gialeli, Nikos K. Karamanos, Panteleimon G. Takis, Anastassios N. Troganis, Athanassios Chrissanthopoulos, George Maroulis & Dionissios Papaioannou, 2016 Jun 1, In : Bioorganic Chemistry. 66, p. 132-144 13 p.

    Research output: Contribution to journalArticle

  6. Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer

    Astrid Escudero-Esparza, Michael Bartoschek, Chrysostomi Gialeli, Marcin Okroj, Sioned Owen, Karin Jirström, Akira Orimo, Wen G. Jiang, Kristian Pietras & Anna M. Blom, 2016, In : Oncotarget. 7, 47, p. 76920-76933 14 p.

    Research output: Contribution to journalArticle

  7. Emerging aspects of nanotoxicology in health and disease: From agriculture and food sector to cancer therapeutics.

    Zoi Piperigkou, Konstantina Karamanou, Ayse Basak Engin, Chrysostomi Gialeli, Anca Oana Docea, Demitrios H Vynios, Mauro S G Pavão, Kirill S Golokhvast, Mikhail I Shtilman, Athanassios Argiris, Ekaterina Shishatskaya & Aristidis M Tsatsakis, 2016, In : Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 91, May, p. 42-57

    Research output: Contribution to journalReview article

  8. 2015
  9. Extracellular matrix structure.

    Achilleas D Theocharis, Spyros S Skandalis, Chrysostomi Gialeli & Nikos K Karamanos, 2015, In : Advanced Drug Delivery Reviews.

    Research output: Contribution to journalReview article